Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-course Hypofractionated RT + Chemo in Locally Advanced NSCLC
NCT04212052Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2020
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Sun Yat-sen University. Primary endpoint: Progression-free survival at 2 years. Started Jul 2020; status: completed.
Beyond the preview
Go deeper on NCT04212052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04212052.